STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs

April 14, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
Bristol Myers Squibb has agreed to pay up to $11 million to settle a lawsuit that accused several drugmakers of conspiring to block generic competition to HIV medicines.

Click to view original post

Related Articles

No Picture
News

STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill

March 15, 2023 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill

The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physician offices. […]

No Picture
News

STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial

October 28, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial

Amid sporadic shortages of a cancer drug, one manufacturer is selling its medicine for 10 to 20 times the prices offered by the only other suppliers. […]